Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: HAE stock price vs MMC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MMC's multiple
Needs MMC P/E.
Implied fair value · at HAE's multiple
Needs HAE P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HAE FY 2026 (ended Mar 28, 2026) · MMC FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 79% equity / 21% debt · EV / Revenue 4.26x · EV / EBITDA 21.58x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Haemonetics Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Marsh & McLennan Companies, Inc. · implied price per share
Bear
$76.37
Base
$95.86
Bull
$121.24
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.56x
1.36x
Net debt / EBITDA
Leverage against operating earnings
3.80x
2.50x
Cash and equivalents
Liquid reserves on the balance sheet
$245.44M
$2.69B
Total debt
Interest-bearing obligations outstanding
$1.24B
$20.85B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BECTON DICKINSON & CO
HAE vs BDX
BAXTER INTERNATIONAL INC
HAE vs BAX
LivaNova PLC
HAE vs LIVN
STERIS plc
HAE vs STE
Aon plc
HAE vs AON
Arthur J. Gallagher & Co.
HAE vs AJG
BROWN & BROWN, INC.
HAE vs BRO
AMERICAN INTERNATIONAL GROUP, INC.
HAE vs AIG
Accenture plc
HAE vs ACN
ROBERT HALF INC.
HAE vs RHI
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
